These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 36320345)

  • 1. Looking Back, Looking Forward: Current Medications and Innovative Potential Medications to Treat Alcohol Use Disorder.
    Mason BJ
    Alcohol Res; 2022; 42(1):11. PubMed ID: 36320345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcohol Use Disorder and Alcohol-Associated Liver Disease.
    Ramkissoon R; Shah VH
    Alcohol Res; 2022; 42(1):13. PubMed ID: 36420303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AUD Risk, Diagnoses, and Course in a Prospective Study Across Two Generations: Implications for Prevention.
    Schuckit MA
    Alcohol Res; 2022; 42(1):01. PubMed ID: 35036241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alcohol's Negative Emotional Side: The Role of Stress Neurobiology in Alcohol Use Disorder.
    Sinha R
    Alcohol Res; 2022; 42(1):12. PubMed ID: 36338609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal Alcohol Spectrum Disorders: Awareness to Insight in Just 50 Years.
    Charness ME
    Alcohol Res; 2022; 42(1):05. PubMed ID: 35280841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol and the Adolescent Brain: What We've Learned and Where the Data Are Taking Us.
    Tapert SF; Eberson-Shumate S
    Alcohol Res; 2022; 42(1):07. PubMed ID: 35465194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age, Period, and Cohort Effects in Alcohol Use in the United States in the 20th and 21st Centuries: Implications for the Coming Decades.
    Keyes KM
    Alcohol Res; 2022; 42(1):02. PubMed ID: 35083099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NIAAA: advancing alcohol research for 40 years.
    Warren KR; Hewitt BG
    Alcohol Res Health; 2010; 33(1-2):5-17. PubMed ID: 23579932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in Pharmacotherapy Development: Human Clinical Studies.
    Litten RZ; Falk DE; Ryan ML; Fertig J; Leggio L
    Handb Exp Pharmacol; 2018; 248():579-613. PubMed ID: 29294197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential medications for the treatment of alcohol use disorder: An evaluation of clinical efficacy and safety.
    Litten RZ; Wilford BB; Falk DE; Ryan ML; Fertig JB
    Subst Abus; 2016; 37(2):286-98. PubMed ID: 26928397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addiction research centres and the nurturing of creativity: the National Institute on Alcohol Abuse and Alcoholism.
    Heilig M; Warren KR; Kunos G; Silverman PB; Hewitt BG
    Addiction; 2011 Jun; 106(6):1052-60. PubMed ID: 20569230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More Treatments on Deck for Alcohol Use Disorder.
    Lyon J
    JAMA; 2017 Jun; 317(22):2267-2269. PubMed ID: 28538998
    [No Abstract]   [Full Text] [Related]  

  • 13. NIAAA's rapid response to college drinking problems initiative: reinforcing the use of evidence-based approaches in college alcohol prevention.
    Dejong W; Larimer ME; Wood MD; Hartman R
    J Stud Alcohol Drugs Suppl; 2009 Jul; (16):5-11. PubMed ID: 19538907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between medication adherence and treatment outcomes: the COMBINE study.
    Zweben A; Pettinati HM; Weiss RD; Youngblood M; Cox CE; Mattson ME; Gorroochurn P; Ciraulo D
    Alcohol Clin Exp Res; 2008 Sep; 32(9):1661-9. PubMed ID: 18616687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the screening suggested by the National Institute on Alcohol Abuse and Alcoholism and of a newly derived tool for the detection of unhealthy alcohol drinkers among surgical patients.
    Agabio R; Gessa GL; Montisci A; Finco G; Contu P; Bedogni G; Marchi A
    J Stud Alcohol Drugs; 2012 Jan; 73(1):126-33. PubMed ID: 22152670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NIAAA 50th Anniversary Festschrift: From the Editor.
    Koob GF
    Alcohol Res; 2022; 42(1):14. PubMed ID: 36420304
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of healthcare utilization among patients treated with alcoholism medications.
    Mark TL; Montejano LB; Kranzler HR; Chalk M; Gastfriend DR
    Am J Manag Care; 2010; 16(12):879-88. PubMed ID: 21348558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adherence Across FDA-Approved Medications for Alcohol Use Disorder in a Veterans Administration Population.
    Walker JR; Korte JE; McRae-Clark AL; Hartwell KJ
    J Stud Alcohol Drugs; 2019 Sep; 80(5):572-577. PubMed ID: 31603760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives on the neuroscience of alcohol from the National Institute on Alcohol Abuse and Alcoholism.
    Reilly MT; Noronha A; Warren K
    Handb Clin Neurol; 2014; 125():15-29. PubMed ID: 25307566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions Between the U.S. National Institute on Alcohol Abuse and Alcoholism and the Alcohol Industry: Evidence From Email Correspondence 2013-2020.
    Mitchell G; McCambridge J
    J Stud Alcohol Drugs; 2023 Jan; 84(1):11-26. PubMed ID: 36799670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.